APPLICATION
ANDA077854
TYPE
ANDA
ORIGINAL APPROVAL
2010-10-08
LATEST ACTION
2024-03-19
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued
Products
PRAMIPEXOLE DIHYDROCHLORIDEDiscontinued
PRAMIPEXOLE DIHYDROCHLORIDE 0.5MG · TABLET · ORAL
PRAMIPEXOLE DIHYDROCHLORIDEDiscontinued
PRAMIPEXOLE DIHYDROCHLORIDE 0.125MG · TABLET · ORAL
PRAMIPEXOLE DIHYDROCHLORIDEDiscontinued
PRAMIPEXOLE DIHYDROCHLORIDE 1MG · TABLET · ORAL
PRAMIPEXOLE DIHYDROCHLORIDEDiscontinued
PRAMIPEXOLE DIHYDROCHLORIDE 0.25MG · TABLET · ORAL
PRAMIPEXOLE DIHYDROCHLORIDEDiscontinued
PRAMIPEXOLE DIHYDROCHLORIDE 1.5MG · TABLET · ORAL
Approval history
2024-03-19Labeling · Supplement 11 · standardAP
2024-03-19Labeling · Supplement 9 · standardAP
2024-03-19Labeling · Supplement 7 · standardAP
2024-03-19Labeling · Supplement 8 · standardAP
2024-03-19Labeling · Supplement 6 · standardAP
2024-03-19Labeling · Supplement 4 · standardAP
2013-08-08Labeling · Supplement 2 · standardAP
2010-10-08OriginalAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.